Several biotechnology companies have recently announced substantial layoffs as part of strategic realignments and cost-saving measures. Enlivex is cutting 60% of its staff, while EyePoint is halving its workforce. Caribou Biosciences is halting pipeline development and laying off employees to seek strategic alternatives. Adecto Pharmaceuticals is shutting down operations entirely due to funding challenges. Foghorn Therapeutics is also reducing its workforce by 40% following a failed collaboration.
https://www.fiercebiotech.com/biotech/fierce-biotech-layoff-tracker-2026